DAM
Draper Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,892
| Closed | -$426K | – | 18 |
|
|
2024
Q2 | $426K | Sell |
7,892
-20
| -0.3% | -$1.08K | 0.32% | 17 |
|
|
2024
Q1 | $521K | Sell |
7,912
-171
| -2% | -$11.3K | 0.45% | 16 |
|
|
2023
Q4 | $506K | Buy |
8,083
+36
| +0.4% | +$2.25K | 0.48% | 14 |
|
|
2023
Q3 | $365K | Sell |
8,047
-76
| -0.9% | -$3.45K | 0.39% | 19 |
|
|
2023
Q2 | $456K | Sell |
8,123
-221
| -3% | -$12.4K | 0.45% | 17 |
|
|
2023
Q1 | $377K | Sell |
8,344
-2,522
| -23% | -$114K | 0.48% | 15 |
|
|
2022
Q4 | $442K | Buy |
10,866
+798
| +8% | +$32.4K | 0.61% | 17 |
|
|
2022
Q3 | $658K | Buy |
10,068
+801
| +9% | +$52.4K | 0.8% | 16 |
|
|
2022
Q2 | $563K | Buy |
9,267
+1,056
| +13% | +$64.2K | 0.66% | 17 |
|
|
2022
Q1 | $515K | Buy |
8,211
+1,202
| +17% | +$75.4K | 0.43% | 19 |
|
|
2021
Q4 | $531K | Buy |
7,009
+1,308
| +23% | +$99.1K | 0.43% | 17 |
|
|
2021
Q3 | $638K | Buy |
5,701
+910
| +19% | +$102K | 0.6% | 19 |
|
|
2021
Q2 | $776K | Buy |
4,791
+1,094
| +30% | +$177K | 0.77% | 17 |
|
|
2021
Q1 | $450K | Buy |
3,697
+1,937
| +110% | +$236K | 0.48% | 22 |
|
|
2020
Q4 | $269K | Buy |
+1,760
| New | +$269K | 0.27% | 29 |
|